Managing Sleep Issues in an Elderly Female Patient
Begin with a structured 12-question sleep assessment at the initial visit to identify the specific type of sleep disturbance, followed immediately by cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, reserving medications only for cases where CBT-I fails. 1, 2
Initial Assessment
Administer a brief sleep questionnaire during routine vital signs assessment, ideally with a bed partner present to assist with answers 1:
Essential Screening Questions
- Sleep timing and duration: Normal bedtime, wake time, and total sleep needed to feel alert 1
- Sleep initiation problems: Difficulty falling asleep at night 1
- Sleep maintenance issues: Number of nighttime awakenings and ability to return to sleep 1
- Sleep-disordered breathing symptoms: Snoring, gasping, or breathing pauses reported by bed partner 1
- Movement disorders: Kicking, thrashing, or urge to move legs during rest 1
- Daytime consequences: Excessive daytime sleepiness, unplanned dozing, or need for naps 1
- Current sleep medications: Any preparations currently used for sleep 1
Critical Comorbidity Assessment
- Medication review: Identify drugs that disrupt sleep including β-blockers, bronchodilators, corticosteroids, decongestants, diuretics, SSRIs, and SNRIs 2, 3
- Medical conditions: Screen for depression (2.5x increased insomnia risk), respiratory symptoms (40% increased risk), chronic pain, and thyroid dysfunction 1, 3, 4
- Behavioral factors: Evaluate daytime napping, excessive time in bed, insufficient activity, evening alcohol consumption, and late heavy meals 2
The key pitfall here is assuming sleep problems are a normal part of aging—they are not. Sleep disruption in elderly patients typically results from medical comorbidities, medications, or specific sleep disorders, all of which are treatable 1
First-Line Treatment: Cognitive Behavioral Therapy for Insomnia (CBT-I)
CBT-I must be initiated as the primary treatment before any pharmacological intervention, as it provides superior long-term outcomes with effects sustained for up to 2 years in older adults without medication-related risks 2, 3
Core CBT-I Components to Implement
Sleep Restriction/Compression Therapy 2:
- Have patient keep a 2-week sleep log documenting actual sleep time
- Limit time in bed to match actual sleep time (compression is better tolerated than immediate restriction in elderly)
- Gradually increase time in bed as sleep efficiency improves
Stimulus Control Therapy 2:
- Use bedroom only for sleep and sex
- Leave bedroom if unable to fall asleep within 20 minutes
- Maintain consistent sleep and wake times daily
- Avoid daytime napping
Sleep Hygiene Modifications 2, 3:
- Ensure bedroom is cool, dark, and quiet
- Avoid caffeine, nicotine, and alcohol in the evening
- Avoid heavy exercise within 2 hours of bedtime
- Avoid heavy meals late in the evening
- Progressive muscle relaxation
- Guided imagery
- Diaphragmatic breathing exercises at bedtime
Critical caveat: Sleep hygiene education alone is insufficient for chronic insomnia and must be combined with other CBT-I modalities. 2, 4
Pharmacological Treatment (Only After CBT-I Failure)
Medications should only be considered when CBT-I alone has been unsuccessful, using shared decision-making that discusses benefits, harms, and costs of short-term use. 2, 4
Medication Selection Based on Symptom Pattern
For Sleep Onset Insomnia 2:
- Ramelteon (melatonin receptor agonist) - favorable safety profile in elderly 4
- Short-acting Z-drugs (zolpidem 5 mg reduced dose for elderly) 3
For Sleep Maintenance Insomnia 2, 4:
- Low-dose doxepin (3-6 mg) - FDA-approved, high-strength evidence for improving total sleep time and sleep quality in older adults 4
- Suvorexant (orexin receptor antagonist) - limit to <90 days due to next-day impairment risk 4
For Both Onset and Maintenance 2:
- Eszopiclone - demonstrated efficacy in elderly at 1-2 mg doses 5
- Extended-release zolpidem - though carries higher fall and cognitive impairment risk 4
Critical Medications to AVOID in Elderly
Never use the following due to unfavorable risk-benefit profiles 2, 4:
- Benzodiazepines (including temazepam): Higher risk of falls, cognitive impairment, dependence, and worsening dementia 2, 3
- Over-the-counter antihistamines (diphenhydramine): Antimuscarinic effects and tolerance development 4
- Sedating antidepressants (trazodone, amitriptyline, mirtazapine): Only use when comorbid depression/anxiety exists, not for primary insomnia 2
- Herbal supplements (valerian, melatonin): Lack of efficacy and safety data 2
Dosing Principles for Elderly
Start at the lowest available dose due to reduced drug clearance and increased sensitivity to peak effects 2:
- Elderly patients require lower doses of all sleep medications
- Follow patients every few weeks initially to assess effectiveness and side effects
- Employ the lowest effective maintenance dosage
- Taper when conditions allow
Major pitfall: Next-day residual effects are common but often not subjectively perceived by patients, even when objectively impaired. Eszopiclone 3 mg caused psychomotor and memory impairment at 7.5 hours that was still present at 11.5 hours, yet patients did not consistently report feeling sedated 5
Long-Term Management Strategy
For patients requiring chronic hypnotic medication due to severe or refractory insomnia 2:
- Administration may be nightly, intermittent (three nights per week), or as needed
- Patients should receive an adequate trial of CBT-I during long-term pharmacotherapy whenever possible
- Medication tapering and discontinuation are facilitated by CBT-I
- Regular reassessment is necessary to evaluate treatment effectiveness and monitor for adverse effects
Combining CBT-I with pharmacotherapy may provide better short-term outcomes than either modality alone, with medications providing rapid onset relief and behavioral therapy providing longer-term sustained benefit 4
Environmental Modifications for Nursing Home Residents
If the patient is in a nursing home setting, implement multicomponent environmental interventions 2:
- Decrease nighttime noise and light disruption
- Increase daytime physical activity and sunlight exposure
- Decrease time in bed during the day
- Establish consistent bedtime routine
These interventions can reduce nighttime arousals and decrease the duration of nighttime awakenings 2